Glutaminase inhibition as potential cancer therapeutics: current status and future applications
Author:
Affiliation:
1. Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, South Korea
2. Medicinal Chemistry & Pharmacology, Korea National University of Science and Technology, Daejeon, South Korea
Funder
Korea Drug Development Fund
Ministry of Health and Welfare
Korea Research Institute of Chemical Technology
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14756366.2023.2290911
Reference98 articles.
1. On the Origin of Cancer Cells
2. On respiratory impairment in cancer cells;Maurer PH;Science,1954
3. The Emerging Hallmarks of Cancer Metabolism
4. Famine versus feast: understanding the metabolism of tumors in vivo
5. Oncogenic K‐Ras decouples glucose and glutamine metabolism to support cancer cell growth
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Glutamine withdrawal leads to the preferential activation of lipid metabolism in metastatic colorectal cancer;Translational Oncology;2024-10
2. Metabolic vulnerabilities in cancer: A new therapeutic strategy;Critical Reviews in Oncology/Hematology;2024-09
3. Novel allosteric glutaminase inhibitors with macrocyclic structure activity relationship analysis (part 2);Bulletin of the Korean Chemical Society;2024-07
4. The Role of Metabolic Reprogramming in the Tumor Immune Microenvironment: Mechanisms and Opportunities for Immunotherapy in Hepatocellular Carcinoma;International Journal of Molecular Sciences;2024-05-21
5. Potential of CDC25 phosphatases in cancer research and treatment: key to precision medicine;Frontiers in Pharmacology;2024-01-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3